Ledger.Open graph →
SEC Form D · Amendment · filed April 10, 2025

Pheast Therapeutics, Inc

Offering
$75.3M
Sold
$75.3M
Exemption
Rule 506(b)
Industry
Other Technology
Location
Redwood City, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Steven Gillis · Ann Arbor, MIDirectorAmira Barkal · Palo Alto, CADirectorRoy Maute · Redwood City, CAExec · DirectorJacob Vogelstein · Baltimore, MDDirectorIrving Weissman · Palo Alto, CADirectorAmira Barkal · Palo Alto, CADirectorRoy Maute · Redwood City, CAExec · DirectorJacob Vogelstein · Baltimore, MDDirectorIrving Weissman · Palo Alto, CADirectorSteven Gillis · Chicago, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗